Zymergen Ch. 11 Plan Confirmed After Investor Objection
By Ben Zigterman · February 5, 2024, 5:09 PM EST
Biotechnology company Zymergen received confirmation of its Chapter 11 plan Monday at a hearing in Delaware bankruptcy court after resolving an objection to the plan from a class of investors suing...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login